Health & Fitness
SAN DIEGO--([ BUSINESS WIRE ])--Illumina, Inc. (NASDAQ:ILMN) today introduced BaseSpace Apps, a dedicated applications store for BaseSpace, the Companyas genomics cloud computing platform. Informatics solutions available through BaseSpace Apps will allow customers to connect with a growing community of academic, commercial and open source tool providers who are building applications around Illumina data to dramatically simplify and accelerate genomic data analysis.
"The rapid adoption of BaseSpace coupled with BaseSpace Apps will help us achieve our goal to create an ecosystem where users of Illumina next generation sequencers can easily access a broad range of genome analysis tools from the worldas leading bioinformatics vendors"
BaseSpace Apps will include a publicly available API (application programming interface) that allows developers to create and deploy new applications for the analysis of genetic data generated on Illumina systems. Diagnomics, GenoLogics Life Sciences, Genomatix, Golden Helix, Ingenuity Systems, Knome, Omicia, Spiral Genetics, Omixon, Real Time Genomics, Station X, Integromics Inc., Biomax Informatics AG, and Strand Life Sciences were named as initial application development partners.
aThe rapid adoption of BaseSpace coupled with BaseSpace Apps will help us achieve our goal to create an ecosystem where users of Illumina next generation sequencers can easily access a broad range of genome analysis tools from the worldas leading bioinformatics vendors,a said Alex Dickinson, Illuminaas Senior Vice President, Cloud Genomics. aBy providing an open API and collaborative environment, we can encourage more rapid proliferation of the tools that will enable scientists to analyze, understand and make use of massive amounts of genetic data.a
Illumina also introduced its iSAAC genome alignment tool today. Historically, alignment has been the most time consuming and processor-intensive step in genome analysis. Available on BaseSpace as well as standard workstations, iSAAC maps sequencing reads to their proper location up to 10 times faster than existing aligners, significantly expediting and simplifying a critical component in data analysis.
Through BaseSpace Apps, a diverse array of new data analysis applications and programs such as iSAAC will be available as part of a growing toolset within the BaseSpace cloud for MiSeq and HiSeq systems. Collectively, the tools will provide a wide range of functionality, from workflow management and downstream data analysis, to data visualization and biological interpretation.
BaseSpace is a scalable cloud-computing environment for all of Illuminaas sequencing systems that can be accessed securely from anywhere in the world. MiSeq system data already can be seamlessly transferred to BaseSpace for storage, analysis and sharing between researchers and their peers around the world, all in a secure and user-friendly environment. HiSeq data storage and analysis capabilities will be commercially released later this year.
About Illumina
Illumina ([ www.illumina.com ]) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.
Forward-Looking Statements
This release contains forward looking statements that involve risks and uncertainties. Examples of forward-looking statements include, but are not limited to, statements we make regarding the expected availability dates for BaseSpace Apps and related data analysis applications and programs. Important factors that could cause actual results to differ materially from those in any forward-looking statements include challenges inherent in developing and launching new products and services and the other factors that are detailed in our filings with the Securities and Exchange Commission, including our most recent filings on Forms 10-K and 10-Q, or in information disclosed in public conference calls, the date and time of which are released beforehand. We do not intend to update any forward-looking statements after the date of this release.